FDA Generative AI Regulatory Guidance — Framework for AI-Powered Devices (Updated 2026)
OVERVIEWThe FDA is developing regulatory guidance for generative AI-enabled medical devices, proposing competency-based assessment approaches that treat AI systems more like physicians than traditional devices. The framework addresses how to evaluate AI systems that can learn and adapt after authorization. Key elements include: competency-based performance assessment rather than fixed thresholds, post-market surveillance for adaptive systems, transparency requirements about AI decision-making, evidence standards for generative AI, and governance frameworks for autonomous AI decision-making. The FDA's competency-based approach acknowledges that traditional medical device regulation—locking specifications at authorization—is inadequate for generative AI. New frameworks enable AI systems to improve over time while maintaining oversight and accountability. UPDATED: 2026 guidance development continues with industry input, with expected publication in 2026-2027. FDA is also considering how competency-based frameworks apply to other adaptive AI systems beyond medical devices. ---
Subscribe to read full wiki analysis
Full wiki content — including source provenance, contradiction tracking, related pages, and analyst notes — is available to Subscriber members.
View Plans & SubscribeNew users get a 7-day trial — no credit card required.